News

Alpha Lifetech Incorporation is revolutionizing the field of biotechnology by offering comprehensive upstream and downstream services tailored for recombinant proteins. With a focus on delivering high-quality protein resources, Alpha Lifetech aims to streamline research and development processes for biopharmaceutical companies. By providing innovative solutions that cater to the industry's specific needs, the company ensures efficient production and purification of proteins. This initiative enhances the capabilities of scientists and researchers and positions Alpha Lifetech as a leader in the biotechnology sector. With a commitment to advancing protein technologies, Alpha Lifetech Incorporation is poised to make significant contributions to scientific breakthroughs and therapeutic developments.

Alpha Lifetech Incorporation has announced a comprehensive review of protein purification, an essential step in the protein production process. The review provides key insights and important points for subsequent experiments and research in the field of protein purification. This review is expected to significantly contribute to the advancement of protein production and development of new therapeutic targets. Alpha Lifetech Incorporation is known for its expertise in biopharmaceutical manufacturing and is committed to providing cutting-edge solutions for protein purification. This review is anticipated to have a major impact on the industry and solidify Alpha Lifetech's position as a leader in biopharmaceutical research and development.

On June 1, 2024, in the journal Nature Communications, scientists from Bo Li's research team published an article titled "Area postrema neurons mediate interleukin-6 function in cancer cachexia". The article found that sustained elevation of interleukin-6 can lead to brain dysfunction and ultimately cancer cachexia.

On July 11, 2024, a team of researchers led by Dr. Judith Sebolt Leopold designed a kinase inhibitor MTX-531 that can block epidermal growth factor receptor (EGFR) and phosphatidylinositol 3-OH kinase (PI3K).

Alpha Lifetech's 700+ biosimilar antibodies target EGFR, TNF-α, VEGF, speeding up drug research with validated quality.

Alpha Lifetech offers quality membrane proteins for drug discovery and cellular insights, using advanced production techniques.

Discover nanobody technology: phage display, immunization, screening, selection, and structural analysis at Alpha Lifetech for diagnostics and therapy.